| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.23 | 4e-06 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |